Why Did Stan Druckenmiller Sell Broadcom Stock?
In Q3, legendary macro investor Stan Druckenmiller sold his entire…
Sell
29
THLEF Quote, Financials, Valuation and Earnings
Last price:
$279.80
Seasonality move
:
4.21%
Day range:
$265.80 - $271.90
52-week range:
$141.80 - $333.38
Dividend yield:
1.62%
P/E ratio:
74.02x
P/S ratio:
2.35x
P/B ratio:
6.50x
Volume:
709
Avg. volume:
1.9K
1-year change:
87.45%
Market cap:
$54.6B
Revenue:
$22.3B
EPS (TTM):
$5.66
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Thales SA has -- downside to fair value with a price target of -- per share.
THLEF vs. S&P 500
-
Over the past 5 trading days, Thales SA has underperformed the S&P 500 by -0.71% suggesting its relative strength compared to the major market average is weak at this time.
Share Buyback
-
Thales SA does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Thales SA has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Thales SA reported revenues of --.
Earnings Growth
-
Thales SA has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Thales SA reported earnings per share of --.
Enterprise value:
58.5B
EV / Invested capital:
--
Price / LTM sales:
2.35x
EV / EBIT:
32.23x
EV / Revenue:
2.49x
PEG ratio (5yr expected):
1.13x
EV / Free cash flow:
20.02x
Price / Operating cash flow:
20.16x
Enterprise value / EBITDA:
19.07x
Gross Profit (TTM):
$6.1B
Return On Assets:
2.77%
Net Income Margin (TTM):
4.6%
Return On Equity:
14.65%
Return On Invested Capital:
7.1%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-01-02 | 2025-01-02 | 2025-01-02 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2021-06-30 | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $20B | $21B | $23.8B | $21.3B | $24.7B | |
| Total Assets | $36.8B | $34.8B | $38.2B | $40.9B | $45.6B | |
| Current Liabilities | $20B | $20.6B | $23.5B | $25.3B | $30B | |
| Total Liabilities | $29.8B | $26.7B | $30.3B | $33B | $37.2B | |
| Total Equity | $7B | $8.1B | $7.9B | $7.9B | $8.4B | |
| Total Debt | $7.5B | -- | -- | -- | -- | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2024-01-02 | 2025-01-02 | 2025-01-02 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
THLEF
Sector
Market Cap
$54.6B
$486.6M
Price % of 52-Week High
79.73%
79.79%
Dividend Yield
1.62%
0%
Shareholder Yield
1.58%
1.52%
1-Year Price Total Return
87.45%
--
Beta (5-Year)
0.004
0.534
Dividend yield:
1.62%
Annualized payout:
$3.72
Payout ratio:
-77.68%
Growth streak:
4 years
Technicals
8-day SMA
Sell
Level
$266.73
200-day SMA
Sell
Level
$280.94
Bollinger Bands (100)
Sell
Level
261.94 - 297
Chaikin Money Flow
Sell
Level
-538
20-day SMA
Buy
Level
$265.36
Relative Strength Index (RSI14)
Sell
Level
48.12
ADX Line
Buy
Level
20.57
Williams %R
Neutral
Level
-70.3641
50-day SMA
Sell
Level
$273.39
MACD (12, 26)
Buy
Level
73.26
25-day Aroon Oscillator
Buy
Level
40
On Balance Volume
Neutral
Level
176
Financial Scores
Sell
Altman Z-Score
(Annual)
Level (1.2261)
Sell
CA Score
(Annual)
Level (-1.5081)
--
Beneish M-Score
(Annual)
Level (--)
--
Momentum Score
Level (--)
Sell
Ohlson Score
Level (1.0944)
Buy
Piotroski F Score
(Annual)
Level (6)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Thales SA is a holding company that engages in the manufacture, marketing, and sale of electronic equipment and systems for aeronautics, naval, and defense sectors. It operates through the following segments: Defence, Aerospace, and Cyber & Digital. The Defence segment provision security and protection of citizens and infrastructures. The Aerospace segment offers aviation safety, designs satellites, earth observation and climate monitoring. The Cyber & Digital segment protects infrastructures and digital services from cyberattacks. The company was founded in 1893 and is headquartered in Paris, France.
Stock Forecast FAQ
In the current month, THLEF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The THLEF average analyst price target in the past 3 months is --.
-
Where Will Thales SA Stock Be In 1 Year?
According to analysts, the consensus estimate is that Thales SA share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Thales SA?
Analysts are divided on their view about Thales SA share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Thales SA is a Sell and believe this share price will rise from its current level to --.
-
What Is Thales SA's Price Target?
The price target for Thales SA over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is THLEF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Thales SA is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of THLEF?
You can purchase shares of Thales SA via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Thales SA shares.
-
What Is The Thales SA Share Price Today?
Thales SA was last trading at $279.80 per share. This represents the most recent stock quote for Thales SA. Yesterday, Thales SA closed at $265.80 per share.
-
How To Buy Thales SA Stock Online?
In order to purchase Thales SA stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
Related Companies
Get THLEF Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
THLEF
Sector
P/E ratio
74.02x
19.19x
PEG ratio
1.13x
0.18x
P/B ratio
6.50x
1.69x
Price / LTM sales
2.35x
0.85x
Growth Metrics
THLEF
Sector
Revenue growth
--
5.01%
Earnings growth
--
5.65%
Revenue (5-year growth)
1.57%
4.27%
Earnings forecast
--
$0.35
Profitability
THLEF
Sector
Profitability FY 2024
$5.8B
$252.3M
Return on invested capital
7.1%
4.72%
Return on assets
2.77%
3.09%
Return on equity
14.65%
8.11%
Earnings Date
Last Earnings Date
Jul
23
Next Earnings Date
Mar
3
Estimated Next Earnings Date
Oct
22
Balance Sheet
THLEF
Sector
Total cash
$4.6B
$138.8M
Short term investments
$936.5K
$32.3M
Total assets
$41.4B
$1.4B
Long term debt
--
$49.5M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Why Is CoreWeave Stock Down So Much?
AI cloud computing business CoreWeave (NASDAQ:CRWV) has been through a…
Why Did Stan Druckenmiller Buy MercadoLibre Stock?
In Q3, billionaire Stan Druckenmiller bought about 4,620 shares of…
Stock Ideas
Buy
55
Is NVDA Stock a Buy?
Market Cap: $4.5T
P/E Ratio: 63x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Sell
30
CORT alert for Jan 2
Corcept Therapeutics, Inc. [CORT] is up 6.12% over the past day.
Buy
75
AXSM alert for Jan 2
Axsome Therapeutics, Inc. [AXSM] is down 3.13% over the past day.
Sell
50
NUTX alert for Jan 2
Nutex Health, Inc. [NUTX] is down 7.67% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
